Medini Reddy-Luthmoodoo
Overview
Explore the profile of Medini Reddy-Luthmoodoo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Varsamis P, Formosa M, Larsen R, Reddy-Luthmoodoo M, Jennings G, Cohen N, et al.
Clin Nutr
. 2018 Sep;
38(4):1536-1543.
PMID: 30217471
Background & Aims: Chronic overconsumption of sugar-sweetened beverages (SSBs) is associated with unfavourable health effects, including promotion of obesity. However, the acute effects of consuming SSBs on glucose and lipid...
2.
Bergouignan A, Latouche C, Heywood S, Grace M, Reddy-Luthmoodoo M, Natoli A, et al.
Sci Rep
. 2016 Aug;
6:32044.
PMID: 27554943
Epidemiological studies have observed associations between frequent interruptions of sitting time with physical activity bouts and beneficial metabolic outcomes, even in individuals who regularly exercise. Frequent interruptions to prolonged sitting...
3.
Siebel A, Trinh S, Formosa M, Mundra P, Natoli A, Reddy-Luthmoodoo M, et al.
Metabolism
. 2016 May;
65(6):904-14.
PMID: 27173469
Aims: High-density lipoprotein (HDL) and apolipoprotein A-I (apoA-I) can modulate glucose metabolism through multiple mechanisms. This study determined the effects of a novel bromodomain and extra-terminal (BET) inhibitor (RVX-208) and...
4.
Latouche C, Natoli A, Reddy-Luthmoodoo M, Heywood S, Armitage J, Kingwell B
PLoS One
. 2016 May;
11(5):e0155108.
PMID: 27163678
Background: The regulation of microRNAs (miRNAs) at different stages of the progression of type 2 diabetes mellitus (T2DM) and their role in glucose homeostasis was investigated. Methods: Microarrays were used...
5.
Carey A, Vorlander C, Reddy-Luthmoodoo M, Natoli A, Formosa M, Bertovic D, et al.
PLoS One
. 2014 Mar;
9(3):e91997.
PMID: 24642703
Introduction: Brown adipose tissue (BAT) is a potential therapeutic target to reverse obesity. The purpose of this study was to determine whether primary precursor cells isolated from human adult subcutaneous...
6.
Ahimastos A, Latouche C, Natoli A, Reddy-Luthmoodoo M, Golledge J, Kingwell B
Circ Res
. 2014 Jan;
114(7):1144-55.
PMID: 24397981
Rationale: We recently reported that ramipril more than doubled maximum walking times in patients with peripheral artery disease with intermittent claudication. Objective: Our aim was to conduct exploratory analyses of...
7.
Siebel A, Natoli A, Yap F, Carey A, Reddy-Luthmoodoo M, Sviridov D, et al.
Circ Res
. 2013 May;
113(2):167-75.
PMID: 23676183
Rationale: High-density lipoprotein cholesterol elevation via cholesteryl ester transfer protein (CETP) inhibition represents a novel therapy for atherosclerosis, which also may have relevance for type 2 diabetes mellitus. Objective: The...
8.
Carey A, Siebel A, Reddy-Luthmoodoo M, Natoli A, DSouza W, Meikle P, et al.
PLoS One
. 2013 Feb;
8(2):e56601.
PMID: 23437184
Background: Emerging evidence suggests that high density lipoprotein (HDL) may modulate glucose metabolism through multiple mechanisms including pancreatic insulin secretion as well as insulin-independent glucose uptake into muscle. We hypothesized...
9.
Drew B, Carey A, Natoli A, Formosa M, Vizi D, Reddy-Luthmoodoo M, et al.
J Lipid Res
. 2011 Jan;
52(3):572-81.
PMID: 21224289
We recently demonstrated that reconstituted high-density lipoprotein (rHDL) modulates glucose metabolism in humans via both AMP-activated protein kinase (AMPK) in muscle and by increasing plasma insulin. Given the key roles...